Coverage dated September 25, 2026

'I was happy losing a pound a week' — why this Zepbound patient refused a higher dose

Headline from The Oregonian

A physician advises that GLP-1 patients need not rush dose escalation, and cautions against a third Shingrix booster until more long-term data becomes available.

The Oregonian's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

2 articles, oldest first.

  1. MLive

    Doctors keep pushing GLP-1 doses higher, but this physician says that's not always right (opens MLive)

    Published

    MLive's feed description

    A physician advises that lower GLP-1 doses can be effective for some patients, and cautions against a third Shingrix booster dose until more data are available.

  2. The Oregonian

    'I was happy losing a pound a week' — why this Zepbound patient refused a higher dose (opens The Oregonian)

    Published

    The Oregonian's feed description

    A physician advises that GLP-1 patients need not rush dose escalation, and cautions against a third Shingrix booster until more long-term data becomes available.

'I was happy losing a pound a week' — why this Zepbound patient refused a higher dose | Since Then